CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 23.10
  • +0.26+1.14%
Not Open Jan 20 15:00 CST
3.68BMarket Cap32.08P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Konruns Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.283B--
--2024/FY-- / 1.077B--
--2023/FY920.012M / 1.049B--
--2022/FY866.726M / 877.000M--
--------

Unlock Free Earnings Estimates

Beijing Konruns Pharmaceutical Earnings Reports

  • Kangchen Pharmaceutical\'s 2024 Third Quarter Report

    Oct 29, 2024 12:00 ET

  • Kangchen Pharmaceutical 2024 Semi-Annual Report

    Aug 27, 2024 12:00 ET

  • Summary of Kangchen Pharmaceutical\'s 2024 Semi-Annual Report

    Aug 27, 2024 12:00 ET

  • Kangchen Pharmaceutical's Announcement on Corrections to the 2023 Annual Report and Annual Report Summary

    May 5, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 20, 2025

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+2.40%
    Innovative Drugs
    Innovative Drugs
    Intraday+2.07%
    Civil-military Integration
    Civil-military Integration
    Intraday+1.01%